Abstract: The cause of early-onset hearing loss is often an underlying genetic condition; clinical guidelines recommend genetic testing as the best medical practice. A genetic diagnosis may help inform medical management and decision-making by providing information about the likelihood of a syndromic condition, whether hearing loss is expected to be stable or progressive, the inheritance risk, and the potential of clinical interventions.
Several gene therapy clinical trials for inner ear disorders are ongoing, and genetic diagnosis may be a critical eligibility criterion. Increasing awareness of genetic testing for potentially eligible individuals will better enable families to consider all potential treatment options
Disclaimer:
In accordance with the Pharmaceutical Research and Manufacturers of America Code on Interactions with Healthcare Professionals (PhRMA Code), CEU cannot be provided for this session."
Learning Objectives:
Describe the commonality of genetic hearing loss and how genetic testing can inform care.
